Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.450
+0.140 (4.23%)
Feb 18, 2026, 4:00 PM EST - Market closed
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $373.37 million as of February 18, 2026. Its market cap has decreased by -61.86% in one year.
Market Cap
373.37M
Enterprise Value
175.65M
1-Year Change
-61.86%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $373.37M, an increase of 291.78%. That is a compound annual growth rate of 13.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 358.20M | -5.71% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 371.24M |
| Vanda Pharmaceuticals | 366.47M |
| Bicycle Therapeutics | 362.79M |
| Monopar Therapeutics | 362.30M |
| Atea Pharmaceuticals | 359.38M |
| Adlai Nortye | 354.98M |
| Benitec Biopharma | 354.71M |
| Aclaris Therapeutics | 353.21M |